Global diabetic kidney disease Market
Healthcare Services

How Will the Diabetic Kidney Disease Market Grow? Key Trends and Opportunities for 2025 and Beyond

Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!

What is the Expected Growth Rate of the Diabetic Kidney Disease Market Based on Industry Projections?

In the past few years, there has been substantial growth in the diabetic kidney disease market size. The market is projected to expand from $2.67 billion in 2024 to $2.81 billion in 2025, with a compound annual growth rate (CAGR) of 5.2%. Factors that accounted for the growth during the historic period include better comprehension of diabetes-related complications, improved diagnostic methods, the formulation of ace inhibitors and arbs, and the implementation of clinical tests, treatment instructions, guiding principles, and disease management protocols.

In the coming years, a significant increase is projected in the market size of diabetic kidney disease. Its expected value by 2029 is $3.56 billion, with a compound annual growth rate (CAGR) of 6.1%. Multiple factors, such as the progression in personalized medicine and biomarker development, a global rise in diabetes, attention towards disease alteration treatments, and changes in health care policies and reimbursement, fuel this growth. Key trends for the forecast period comprise the progress in renal replacement therapies, a precision medicine approach, emphasis on preventive detection and diagnosis, revolutionary therapeutic developments, and an increase in managing comorbidities.

How Are Key Drivers in the Industry Acting as Catalysts for the Growth of the diabetic kidney disease Market?

The diabetic kidney disease market is projected to expand due to the increasing occurrence of chronic kidney disease. Chronic kidney disease (CKD) is a long-term malady that gradually destroys kidney efficiency, leading to health issues like high blood pressure, anemia, and bone disorders. As a result, the need for diagnostic and treatment alternatives fosters the diabetic kidney disease market’s growth. For example, data from Kidney Research UK in June 2023, a prominent UK charity, indicated that approximately 7.2 million people in the UK, over 10% of the population, suffered from CKD. Among them, 3.25 million were experiencing the most severe phases of the disease, and around 3.9 million were in the early stages, often undiagnosed and without symptoms. The total number of people with chronic kidney conditions in the UK could escalate to 7.61 million by 2033, according to estimates. Consequently, the increasing frequency of chronic kidney disease plays a key role in propelling the diabetic kidney disease market in the future.

Request Your Free Diabetic Kidney Disease Market Report Sample Now!

https://www.thebusinessresearchcompany.com/sample.aspx?id=9932&type=smp

Who Are the Dominant Players Expanding Their Reach in the Diabetic Kidney Disease Market?

Major companies operating in the diabetic kidney disease market include:

• AstraZeneca plc_x000D_

• Pfizer Inc._x000D_

• Novartis AG_x000D_

• Bayer AG_x000D_

• Sanofi SA_x000D_

What Are the Top Trends Shaping the Evolution of the Diabetic Kidney Disease Market?

Innovations in technology represent a growing trend in the diabetic kidney disease market. Firms in this market are endorsing state-of-the-art technologies to maintain their market presence. For example, Bloom Diagnostics, a US medical diagnostics and health devices company, introduced the Bloom Kidney Test in August 2022. This innovative tool, which can be synchronized with the Bloom Smart System, evaluates kidney health by analyzing cystatin C levels, which is a dependable measure of kidney function. Kidney functionality is categorised into three groups: healthy, slightly decreased, and reduced. The Bloom Smart System employs artificial intelligence and cloud-based algorithms to correlate test results with other significant health data, such as the patient’s medical history, lifestyle, and symptoms.

Pre-order Your Report for Quick and Easy Delivery!

https://www.thebusinessresearchcompany.com/report/diabetic-kidney-disease-global-market-report

Which Key Segments Stand Out in Understanding the Composition of the Diabetic Kidney Disease Market?

The diabetic kidney disease market covered in this report is segmented –

1) By Type: Type 1 Diabetes, Type 2 Diabetes

2) By Treatment: Angiotensin Receptor Blockers (Arbs), Angiotensin-Converting Enzyme (Ace) Inhibitors, Antioxidant Inflammation Modulator, Calcium Channel Blockers, Other Treatments

3) By End User: Hospitals, Homecare, Specialty Centers, Other End Users

Subsegments:

1) By Type 1 Diabetes: Autoimmune-Related Diabetic Kidney Disease, Early-Onset Diabetic Kidney Disease

2) By Type 2 Diabetes: Obesity-Related Diabetic Kidney Disease, Late-Onset Diabetic Kidney Disease

Which Regions Are Setting the Pace for Diabetic Kidney Disease Market Growth?

North America was the largest region in the diabetic kidney disease market in 2024. The regions covered in the diabetic kidney disease market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

What Defines the Scope of the Diabetic Kidney Disease Market?

Diabetic kidney disease refers to a type of renal disease driven by complications of diabetes that occurs when high levels of blood sugar cause damage to the kidneys. The blood vessels in the kidneys can become affected by high blood glucose, which ultimately reduces their functionality.

Browse Through More Similar Reports By The Business Research Company:

Analytical Laboratory Instrument Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/analytical-laboratory-instrument-global-market-report

Healthcare Analytical Testing Services Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/healthcare-analytical-testing-services-global-market-report

Pharmaceutical Contract Development And Manufacturing Organization (CMO) Global Market Report 2024

https://www.thebusinessresearchcompany.com/report/pharmaceutical-contract-developments-and-manufacturing-organization-cmo-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on:

Leave a Reply

Your email address will not be published. Required fields are marked *